Saudi Arabia Microbial Api Market Size & Outlook
Related Markets
Saudi Arabia microbial api market highlights
- The Saudi Arabia microbial api market generated a revenue of USD 467.2 million in 2023 and is expected to reach USD 546.4 million by 2030.
- The Saudi Arabia market is expected to grow at a CAGR of 2.3% from 2024 to 2030.
- In terms of segment, mammalian was the largest revenue generating host in 2023.
- Mammalian is the most lucrative host segment registering the fastest growth during the forecast period.
Microbial api market data book summary
| Market revenue in 2023 | USD 467.2 million |
| Market revenue in 2030 | USD 546.4 million |
| Growth rate | 2.3% (CAGR from 2024 to 2030) |
| Largest segment | Mammalian |
| Fastest growing segment | Mammalian |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Mammalian, Bacterial, Fungal |
| Key market players worldwide | Merck & Co Inc, DSM, CSPC Pharmaceutical Group Ltd, Teva Pharmaceutical Industries Ltd, Lonza Group Ltd, Takeda Pharmaceutical Co Ltd, Kolon Life Science, Shandong Lukang Pharmaceutical Group |
Other key industry trends
- In terms of revenue, Saudi Arabia accounted for 0.8% of the global microbial api market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, Saudi Arabia microbial api market is projected to lead the regional market in terms of revenue in 2030.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 229.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Microbial API Market Scope
Microbial API Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Shandong Lukang Pharmaceutical Group | View profile | 5001-10000 | Jining, Shandong, China, Asia | http://www.lkpc.com |
| Kolon Life Science | View profile | 251-500 | Seoul, Seoul-t'ukpyolsi, South Korea, Asia | http://www.kolonls.co.kr |
| CSPC Pharmaceutical Group Ltd | View profile | 23500 | No. 226 Huanghe Street, Hebei Province, Shijiazhuang, China, People's Republic of, 050035 | https://www.cspc.com.hk |
| Takeda Pharmaceutical Co Ltd | View profile | 49095 | 1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, Japan, 103-8668 | https://www.takeda.com |
| DSM | View profile | 10001+ | Heerlen, Limburg, The Netherlands, Europe | http://www.dsm.com |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| Lonza Group Ltd | View profile | 18000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | https://www.lonza.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
Saudi Arabia microbial api market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to microbial api market will help companies and investors design strategic landscapes.
Mammalian was the largest segment with a revenue share of 47.37% in 2023. Horizon Databook has segmented the Saudi Arabia microbial api market based on mammalian, bacterial, fungal covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Saudi Arabia microbial api market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Saudi Arabia microbial api market databook
-
Our clientele includes a mix of microbial api market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia microbial api market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia microbial api market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Saudi Arabia Host - Microbial Api Market size, 2023 - 2030 (US$M)
Saudi Arabia Microbial API Market Outlook Share, 2023 & 2030 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
